The future of PDGF research in cancer looks promising, with advancements in molecular biology and genomics providing deeper insights into the complexities of PDGF signaling. Emerging technologies such as CRISPR-Cas9 and single-cell RNA sequencing are expected to elucidate the specific roles of PDGFs in different cancer types and stages. Furthermore, combination therapies that target multiple signaling pathways simultaneously are being explored to overcome resistance and improve treatment outcomes.
